MDR1 in Collies: The Breed With the Highest Mutation Rate

No breed carries the MDR1 mutation more frequently than the Collie. Rough Collies and Smooth Collies — which the American Kennel Club registers as varieties of the same breed — have been tested at mutation frequencies ranging from 70% to 75% in large population studies. In practical terms, if you randomly select four Rough Collies off the street, approximately three of them carry at least one copy of the MDR1 mutation. One of those three is fully homozygous affected with no functional P-glycoprotein.

This is the breed that gave MDR1 its original name in veterinary literature. Before the genetics were understood, the condition was called "ivermectin sensitivity in Collies" — a description that captured the clinical phenomenon without explaining its mechanism. When researchers at Washington State University identified the specific genetic mutation in 2001, Collies were the primary study population.

Why Collies Are So Heavily Affected

The MDR1 mutation arose in a single common ancestor of multiple herding breeds, estimated to have occurred before modern breed registries were established. In the ancestral gene pool that gave rise to today's Collie, the mutation appears to have been present at high frequency. As the breed was developed and its population went through the typical bottlenecks of early purebred formation, the mutation frequency was preserved or even amplified.

Population genetics studies suggest that the mutation may have been at high frequency in the ancestor population due to founder effects — the limited number of dogs used to establish the breed meant that whatever genetic variants those founders carried became disproportionately represented. A comprehensive analysis of how MDR1 spread across related herding breeds is available at The Herding Gene, which covers the evolutionary genetics in depth.

Collie-Specific Drug Reaction History

The Collie's relationship with drug toxicity is well-documented in veterinary literature going back decades before the genetic explanation was available. Collie owners and breeders knew empirically that their dogs reacted abnormally to certain medications long before anyone understood why. Documented reaction cases span multiple decades and include:

• Ivermectin toxicity from off-label large animal dosing and mange treatment protocols
• Loperamide deaths from well-intentioned owners treating diarrhea with over-the-counter antidiarrheals
• Prolonged sedation and respiratory complications from standard acepromazine doses
• Enhanced myelosuppression from chemotherapy in cancer treatment

The historical record of these cases, compiled by the Collie Health Foundation and individual breed club health committees, represents some of the earliest systematic documentation of a breed-specific pharmacogenetic sensitivity in veterinary medicine. For a detailed record of documented adverse reactions and their case outcomes, Collie Drug Reactions maintains an extensive case database.

Testing Every Collie: The Ethical Imperative

Given that 70 to 75% of Collies carry at least one copy of the MDR1 mutation, treating an untested Collie as though it is MDR1-clear is statistically unjustifiable. The base rate alone demands caution. Every Rough Collie and Smooth Collie owner should test their dog before the dog's first non-routine veterinary procedure.

Testing is simple. A buccal swab mailed to a laboratory returns results in 5 to 10 business days and costs between $45 and $75. The result is permanent — a dog that tests N/N at six months of age is still N/N at ten years. You test once. Our Testing Options guide compares all major laboratories and explains how to request the test and interpret results.

Collie-Specific Management Considerations

Herding and Working Collies

Working Collies and those competing in herding, agility, or obedience sometimes receive preventive medications in field environments where veterinary oversight is limited. Farmers who use Collies for livestock work have historically been among the highest-risk groups for inadvertent MDR1 toxicity — using the same large-animal ivermectin products available on their properties to deworm their dogs. Any Collie used in working or farm contexts must have a documented MDR1 test result, and that result should be accessible to everyone who cares for the dog.

Show Collies

Show Collies travel extensively, attend events with veterinary professionals who may not know the individual dog, and may be under the care of handlers who are not the primary owner. MDR1 documentation should accompany any Collie that travels to dog shows or events. The handler needs to know the genotype and must be able to communicate it in any emergency medical situation.

Breeding Collies

The high MDR1 mutation frequency in Collies creates a specific breeding challenge. With 70 to 75% of Collies carrying the mutation, breeding only clear-to-clear dogs would eliminate too much of the gene pool and cause unacceptable loss of genetic diversity. The responsible approach is to understand the population-level strategy for gradually reducing mutation frequency over generations without compromising breed health. Our Breeding Decisions guide covers the evidence-based strategies for MDR1 management in high-frequency breeds in detail.

Collie-Specific Drug Protocol

For confirmed M/M Collies, the standard drug avoidance protocols apply. For the large proportion of Collies whose status is unknown or who are confirmed carriers (N/M), a conservative approach is appropriate:

Always Avoid

• Loperamide (Imodium) — no safe dose for M/M; avoid for untested Collies
• Doramectin (Dectomax) — any dose
• High-dose moxidectin or ivermectin beyond heartworm prevention range

Use With MDR1-Aware Dosing

• Acepromazine — reduce to 25-50% of normal dose, monitor prolonged effects
• Butorphanol — reduce dose and monitor respiratory rate
• Chemotherapy agents — follow modified protocols as detailed in our chemotherapy safety guide

Safe at Standard Doses

• Heartworm preventatives (Heartgard, Interceptor, Revolution, Sentinel) at labeled doses
• NSAIDs (carprofen, meloxicam)
• Most antibiotics (not erythromycin)
• Fenbendazole (Panacur) for intestinal parasites
• Vaccines

Collie Health Committees and Resources

The Collie Club of America's health committee has been involved in MDR1 awareness for decades. Their health testing recommendations for breeding stock include MDR1 as a priority test. National breed clubs in the UK (The Rough Collie Association, The Smooth Collie Club) have similar positions.

Connecting with Collie breed-specific health resources provides access to vetted breeder networks who have navigated MDR1 management across generations of dogs. Experienced breeders who have managed M/M dogs in their lines for years have practical knowledge that supplements the clinical guidance in these pages.

For the complete drug-by-drug reference for managing a Collie's medical care safely, our Complete Drug Avoidance List is organized by drug class with specific dose recommendations and safe alternatives for each category.